EUVIMEDEUVIMED entdecken
Crossref

METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA

Chengwu Gong, Jinlong Wu, Hao Li, Congcong Luo, Guangyu Ji, Xin Guan, Jichun Liu, Mingsong Wang

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2023

DOI: 10.1016/j.bbamcr.2023.119503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2023. Verfasst von Chengwu Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China; Department…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Sepsis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Septic cardiomyopathy (SCM) was an important pathological component of severe sepsis and septic shock. N6-methyladenosine (m6A) modification was a common RNA modification in both mRNA and non-coding RNAs and was proved to be involved in sepsis and immune disorders. Therefore, the purpose of this study was to investigate the role and mechanism of METTL3 in lipopolysaccharide-induced myocardial injury. We firstly analyzed the expression changes of various m6A-related regulators in human samples in the GSE79962 data and the Receiver Operating Characteristic curve of significantly changed m6A enzymes, showing that METTL3 had a high diagnostic ability in patients with SCM. Western blotting confirmed the high expression of METTL3 in LPS-treated H9C2 cells, which was consistent with the above results in human samples. In vitro and in vivo, the deficiency of METTL3 could improve the cardiac function, cardiac tissue damage, myocardial cell apoptosis and reactive oxygen species levels in LPS-treated H9C2 cells and LPS-induced sepsis rats, respectively. In addition, we obtained 213 differential genes through transcriptome RNA-seq analysis, and conducted GO enrichment analysis and KEGG pathway analysis through DAVID. We also found that the half-life of Myh3 mRNA was significantly reduced after METTL3 deletion and that Myh3 carried several potential m6A modification sites. In conclusion, we found that downregulation of METTL3 reversed LPS-induced myocardial cell and tissue damage and reduced cardiac function, mainly by increasing Myh3 stability. Our study revealed a key role of METTL3-mediated m6A methylation in septic cardiomyopathy, which may offer a potential mechanism for the therapy of septic cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesSepsisAnimalsHumansRatsMethylationMethyltransferasesMyocytes, CardiacRNA, MessengerCytoskeletal ProteinsMyosin Heavy ChainsAdenosine

Stichwörter der Autor:innen

LPSMETTL3Septic cardiomyopathym(6)A

Substanzen

LipopolysaccharidesMethyltransferasesRNA, MessengerMETTL3 protein, humanMettl3 protein, ratMYH3 polypeptide, humanCytoskeletal ProteinsMyh3 protein, ratMyosin Heavy ChainsN-methyladenosine

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China; Department of Cardiothoracic Surgery, Second Affiliated Hospital, Nanchang Unive…
  • Department of Thoracic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China.
  • Department of Cardiothoracic Surgery, Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, China. Electronic address: 810200871@qq.com.
  • Department of Thoracic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China. Electronic address: wms0210@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gong, C., Wu, J., Li, H., Luo, C., Ji, G., Guan, X., Liu, J., & Wang, M. (2023). METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2023.119503

Vancouver

Gong C, Wu J, Li H, Luo C, Ji G, Guan X, et al. METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2023. doi:10.1016/j.bbamcr.2023.119503

BibTeX
@article{Gong2023,
  author = {Gong, Chengwu and Wu, Jinlong and Li, Hao and Luo, Congcong and Ji, Guangyu and Guan, Xin and Liu, Jichun and Wang, Mingsong},
  title = {METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Cell Research},
  year = {2023},
  doi = {10.1016/j.bbamcr.2023.119503}
}
Kostenlos starten →